Search Results
Nov 26, 2025, 08:02 ET Lumenis' triLift™ Honored in Two Categories on the MedEsthetics 2025 Readers' Choice Awards
measures. My patients love how quickly they notice improved definition and skin quality, making it an integral tool in my practice," said Dr. James Chelnis, MD, FACS, of Manhattan Face and Eye.Since its launch in 2022, triLift has been adopted by leading dermatologists, plastic surgeons and aesthetic physicians
More news about: Lumenis Be. Ltd.
Nov 26, 2025, 07:00 ET Blue Sky Uranium Completes Comprehensive GAP Analysis for Ivana Deposit and Identifies Clear Roadmap to Feasibility
conditions. For additional details, please refer to the News Release dated February 27, 2025, as well as the Company's latest Financial Statements & MD&A available at
More news about: Blue Sky Uranium Corp.
Nov 26, 2025, 06:00 ET Wishpond Returns to Positive Adjusted EBITDA and Achieves Highest Gross Margins Since 2020
"Interim Financial Statements") and management's discussion and analysis (the "MD&A") for Q3-2025, representing the three and nine months ended September 30, 2025. Copies of the Interim Financial Statements and MD&A are available on the Company's profile on SEDAR+ at
More news about: Wishpond Technologies Ltd.
Nov 26, 2025, 06:00 ET Lighthouse Pharmaceuticals To Present Phase 2 SPRING Trial of LHP588, a Next-Generation Gingipain Inhibitor for the Treatment of P. gingivalis-Positive Alzheimer's Disease, at CTAD 2025
significant advancement in our effort to target a bacterial driver of Alzheimer's disease with a high-precision oral medication," said Michael Detke, MD, PhD, Chief Medical Officer at Lighthouse Pharmaceuticals. "By focusing on P. gingivalis–positive patients and integrating biomarker-guided selection
More news about: Lighthouse Pharmaceuticals
Nov 26, 2025, 05:00 ET Department of Education's Loan Proposal Puts Nursing Workforce and Patient Care at Risk
Urge the Department of Education to Protect Graduate Nursing Education and Access to CareSILVER SPRING, Md., Nov. 26, 2025 /PRNewswire/ -- The American Nurses Association (ANA) is deeply concerned by the Department of
More news about: American Nurses Association
Nov 26, 2025, 01:48 ET Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal
with negative long-term outcomes and the fact that the terminal ileum being the most challenging segment to treat," said Prof. Jean-Frédéric Colombel, MD, Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai. "The consistent clinical and endoscopic outcomes observed with subcutaneous
More news about: Celltrion
Nov 26, 2025, 01:22 ET Third Quarter Financial Results: Strauss Group concludes a strong quarter with an increase of 10% in Sales to NIS 3.3 billion and an increase of 43% in Net Income to NIS 146 million
budgets and operational goals and to evaluate the performance of the Company. Please see the GAAP to Non-GAAP reconciliation tables in the Company's MD&A Report for a full reconciliation of the Company's GAAP to Non-GAAP results.
More news about: Strauss Group Ltd.
Nov 26, 2025, 01:00 ET Renalys Pharma Announces Positive Topline Results from Phase III Study of Sparsentan in Japanese Patients with IgA Nephropathy
We extend our deepest gratitude to the patients, investigators, and all those involved in conducting this study."Naoki Kashihara, MD, PhD, President of Japan Kidney Association, commented:"For rare kidney diseases such as IgAN,
More news about: Renalys Pharma, Inc.
Nov 25, 2025, 22:51 ET FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
with acceptable tolerability. This is especially important in this aging population who are dealing with significant comorbidities," said Emily Ruiz, MD, MPH, Associate Professor of Dermatology, Harvard Medical School, Academic Director of the Micrographic Surgery Center at Brigham and Women's Hospital,
More news about: Sun Pharma
Nov 25, 2025, 12:15 ET Winter City Lights in Maryland Wins National Recognition in Newsweek's Readers' Choice Awards
OLNEY, Md., Nov. 25, 2025 /PRNewswire/ -- Winter City Lights, a dazzling holiday Christmas lights festival that boasts more than 1 million twinkling lights, a towering 52-foot Christmas tree draped with a stunning canopy of
More news about: Steelhead Events & Productions
Nov 25, 2025, 10:48 ET Arbor Scientia Group Honored as a 2025 BASA Awards® Winner and Recognized as an Inc. Power Partner for the Second Year in a Row
with the ultimate goal of improving patient lives.Founded by internationally renowned psychiatrist and professor of psychiatry Stephen M. Stahl, MD, PhD, DSc (Hon), DMedSci (Hon, Cambridge), and current CEO Richard Davis, an adult learning and communications expert, ASG sets themselves apart in the
More news about: Arbor Scientia Group
Nov 25, 2025, 10:17 ET Zirkin & Schmerling Injury Lawyers Secures $100,000 Policy-Limits Recovery for Working Professional Injured in Dog Attack
PIKESVILLE, Md., Nov. 25, 2025 /PRNewswire/ -- Zirkin & Schmerling Injury Lawyers is proud to announce a $100,000 policy-limits recovery on behalf of a Maryland working professional who suffered serious injuries and significant
More news about: Zirkin & Schmerling Injury Lawyers
Nov 25, 2025, 10:06 ET uniball National Signing Day™ Is Here to Stay: 70+ High Schools Nationwide Join 2025-26 Celebration
From Archbishop Stepinac High School (NY) to Hamilton Southeastern High School (IN), Mater Dei (CA), Bentonville (AR), IMG Academy (FL) Good Counsel (MD), Brewster (NH), Bishop Gorman (NV), Knoxville Catholic (TN), and Pickerington North (OH), schools nationwide are uniting in this shared celebration of
More news about: uni Brands Corporation
Nov 25, 2025, 10:06 ET Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
Therapeutics was co-founded by Nancy Klauber-DeMore M.D., FACS, Professor of Surgery Medical University of South Carolina (MUSC) and Dr. Cam Patterson, MD, MBA, Former Provost University of Arkansas Medical Center, to identify and develop monoclonal antibody therapies for cancer.Forward Looking
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
Therapeutics was co-founded by Nancy Klauber-DeMore M.D., FACS, Professor of Surgery Medical University of South Carolina (MUSC) and Dr. Cam Patterson, MD, MBA, Former Provost University of Arkansas Medical Center, to identify and develop monoclonal antibody therapies for cancer.Forward Looking
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics bringt mit der Übernahme von Enci Therapeutics eine neuartige Krebsbehandlung voran
Therapeutics wurde von Nancy Klauber-DeMore M.D., FACS, Professorin für Chirurgie an der Medical University of South Carolina (MUSC) und Dr. Cam Patterson, MD, MBA, ehemaliger Provost der University of Arkansas Medical Center, mit dem Ziel gegründet, monoklonale Antikörpertherapien für Krebs zu identifizieren
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics fait progresser un nouveau traitement contre le cancer grâce à l'acquisition d'Enci Therapeutics
Therapeutics a été cofondée par Nancy Klauber-DeMore M.D., FACS, professeur de chirurgie à l'université de Caroline du Sud (MUSC) et par le Dr Cam Patterson, MD, MBA, ancien doyen du centre médical de l'université de l'Arkansas, afin d'identifier et de développer des thérapies à base d'anticorps monoclonaux pour
More news about: Innova Therapeutics
Nov 25, 2025, 10:06 ET Innova Therapeutics impulsará un nuevo tratamiento contra el cáncer con la adquisición de Enci Therapeutics
fue cofundada por Nancy Klauber-DeMore M.D., FACS, profesora de Cirugía de la Universidad Médica de Carolina del Sur (MUSC) y el doctor Cam Patterson, MD, MBA, ex rector del Centro Médico de la Universidad de Arkansas, para identificar y desarrollar terapias con anticuerpos monoclonales para el cáncer.Declaraciones
More news about: Innova Therapeutics
Nov 25, 2025, 09:45 ET To Educate the Public and Raise Awareness, Prevent Blindness Declares Fifth Annual Geographic Atrophy Week as Dec. 1-7, 2025
and Help" forum include:Moderator: Kira Baldonado, MPH, Executive Vice President, Prevent BlindnessJohn W. Kitchens, MD, Retina Specialist, Retina Associates of KentuckyJulie Grutzmacher, MSW, MPH, Director of Patient Advocacy + Population Health Initiatives, Prevent
More news about: Prevent Blindness
Nov 25, 2025, 09:30 ET Appian AI Transforms Clinical Workflows for Global Public Health Agencies
solution lays out a path to safely and efficiently embed multiple types of AI into health workflows using global open standards," said Shane McNamee MD, Industry Lead, Global Public Health at Appian. "By applying AI thoughtfully, we can reduce complexity, improve efficiency, and enable proactive, data-driven
More news about: Appian
Nov 25, 2025, 09:00 ET Aidoc Files Breakthrough FDA Submission for Foundation Model Covering Double-Digit Conditions
performance in any clinical setting, and AI-powered analytics."Patient safety and timely care are at the heart of everything we do," said Neal Patel, MD, MPH, Chief Health Information Officer at Vanderbilt University Medical Center. "aiOS allows us to integrate clinical AI safely and at scale. It's not
More news about: Aidoc
Nov 25, 2025, 09:00 ET Caring Cross and Amrita Research Center Delhi, Amrita Vishwa Vidyapeetham Announce Strategic Partnership to Advance Affordable Cell and Gene Therapies for Underserved Populations Across India
GAITHERSBURG, Md. and FARIDABAD, India, Nov. 25, 2025 /PRNewswire/ --
More news about: Caring Cross
Nov 25, 2025, 08:43 ET In Annapolis, Dr. Sarah Whiteford Brings a More Attentive, Relationship-Centered Approach to Primary Care Through MDVIP
ANNAPOLIS, Md., Nov. 25, 2025 /PRNewswire/ --
More news about: MDVIP
Nov 25, 2025, 08:30 ET Expert.ai Presents EIX-Customer Screening for Intelligent Adverse News Monitoring in the Financial Sector
leading banks and financial institutions to strengthen anti-money laundering and compliance effortsROCKVILLE, Md., Nov. 25, 2025 /PRNewswire/ -- Expert.ai, a leading provider of enterprise AI solutions for business value creation,
More news about: expert.ai
Nov 25, 2025, 08:15 ET Encompass Health and Vanderbilt Health announce plans to build a 40-bed inpatient rehabilitation hospital in Lebanon, Tennessee
serve the needs of these individuals in a state-of-the-art setting staffed by world-class physicians, nurses, therapists and staff," said Jane Freedman, MD, Deputy CEO and Chief Health System Officer for Vanderbilt University Medical Center.About Encompass Health Encompass Health (NYSE:
More news about: Encompass Health Corp.